Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New topoisomerase I inhibitors synthesized at Rutgers

Jan. 13, 1997

New manumycin-class antibiotics isolated at Tanabe Seiyaku

Jan. 10, 1997

Antileukemic bisabolane sesquiterpene isolated from natural sources

Jan. 10, 1997

Three new melanoma vaccines from Therion Biologics enter clinical testing

Jan. 9, 1997

QLT, AHP redefine Photofrin relationship

Jan. 9, 1997

Progress in Sugen's cancer development pipeline

Jan. 9, 1997

OXiGENE and Boston Medical Center announce collaboration

Jan. 9, 1997

Vion receives SBIR grant to develop ribonucleotide reductase inhibitor

Jan. 9, 1997

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

BCH-4556 slated to enter clinical testing

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...